More articles from Volume 44, Issue 2, 2015
Awareness, habits and behaviors associated with the oral health of children in elementary schools on Kosovo and Metohia
Organization and collagen volume density of the gingiva in the patients with periodontitis
Research on presence of chosen risk factors for hypertension in medical students
Impact of adipose specific peptides on the course and prognosis of myocardial heart attacks
Pain and justification from dental intervention
STEM CELL TREATMENT FOR AGE-RELATED NEURODEGENERATIVE DISEASES AUTHORS
,
J. Nurković
,
B. Bisevac
,
F. Mustafić
,
S. Hajrovic
,
E. Regić
,
S. Nurković
,
I. Kurtagić
Z. Dolicanin
Published: 01.06.2015.
Volume 44, Issue 2 (2015)
pp. 103-108;
Abstract
The belief in the inability of neurogenesis, that is the inability to create new neurons after embryonic and early postnatal development of the central nervous system, was rejected in the mid-nineties, when the existence of neurogenesis in restricted areas of CNS adult mammals, including humans, was discovered.Transplantation of stem cells or their derivatives into respective tissues or organs is considered as one of the most promising remedies for many incurable diseases.In this review, we summarized current knowledge and present and future perspectives andchallenges regarding stem cells treatment for Parkinson's and Alzheimer's disease, as the most common age-related neurodegenerative diseases.
Keywords
References
1.
Kolios G, Moodley Y. Introduction to stem cells and regenerative medicine. Respiration. 2013;(1):3–10.
2.
Nurković J, Dolićanin Z, Tutić I, Hajrović Š, Mustafić F, Todorović V, et al. Praxis Medica. 2013;(3):45–50.
3.
Nurković J, Lužajić T, Francuski J, Dolićanin Z, Radovanović A, Todorović V, et al. Potencijal za diferencijaciju mezenhimalnih matičnih ćelija iz masnog tkiva čoveka. 5. Kongres medicine sporta i sportskih nauka sa mađunarodnim učešćem. 2012;10–1.
4.
Volarevic V, Bojic S, Nurkovic J, Volarevic A, Ljujic B, Arsenijevic N, et al. Stem Cells as New Agents for the Treatment of Infertility: Current and Future Perspectives and Challenges. BioMed Res Int. 2014;507234.
5.
Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M. Concise Review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells. 2014;(11):2818–23.
6.
Miguel D, Fuentes-Julian M, Alcaina S, Y. Pluripotent stem cells: origin, maintenance and induction. Stem Cell Rev. 2010;633–49.
7.
Evans M, Kaufman M. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;154–6.
8.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;663–76.
9.
Ishii T, Eto K. Fetal stem cell transplantation: Past, present, and future. World J Stem Cells. 2014;(4):404–20.
10.
Augello A, Kurth T, De B. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater. 2010;121–33.
11.
Barzilay R, Melamed E, Offen D. Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Stem Cells. 2009;2509–15.
12.
Nurkovic J, Mustafic F, Vucelj S, Mahmutovic E, Nurkovic S, Dolicanin Z. Mesenchymal stem cells from dental pulp. EMBO Conference Stem Cells in Cancer and Regenerative Medicine. :157.
13.
Nurković J, Dolićanin Z. Induced differentiation of adipose-derived mesenchymal stem cells. 1st Annual Conference 2013 of the German Stem Cell Network (GSCN). (091):172.
14.
Martínez-Morales P, Revilla A, Ocana I, Gonzalez C, Sainz P, Mcguire D, et al. Progress in stem cell therapy for major human neurological disorders. Stem Cell Rev. 2013;685–99.
15.
Maldonado-Soto A, Oakley D, Wichterle H, Stein J, Doetsch F, Henderson C. Stem cells in the nervous system. Am J Phys Med Rehabil. 2014;(11):132–44.
16.
Johansson P, Cappello S, Gotz M. Stem cells niches during development-lessons from the cerebral cortex. Curr Opin Neurobiol. 2010;400–7.
17.
Rakić P. Limits of neurogenesis in primates. Science. 1985;(4690):1054–6.
18.
Johansson C, Svensson M, Wallstedt L, Janson A, Frisén J. Neuralstem cells in the adult human brain. Exp Cell Res. 1999;(2):733–6.
19.
Obradovic D, Balint B, Dincic E, Raicevic R, Obradovic S, Toncev G, et al. Primenamatičnihćelija u lečenjuneurološkihoboljenja -da li je budućnostvećstigla? Vojnosanit Pregl. 2008;(6):473–80.
20.
Ming G, Song H. Adult neurogenesis in the mammalian centralnervous system. Annu Rev Neurosci. 2005;223–50.
21.
Gage F. Mammalian neural stem cells. Science. 2000;(5457):1433–8.
22.
Robins S, Stewart I, Mcnay D, Taylor V, Giachino C, Goetz M, et al. Nat Commun. 2013;2049.
23.
Lin R, Cai J, Nathan C, Wei X, Schleidt S, Rosenwasser R, et al. Neurogenesis is enhanced by stroke in multiple new stem cell niches along the ventricular system at sites of high BBB permeability. Neurobiol Dis. 2015;229–39.
24.
Koutmani Y, Karalis K. Neural stem cells respond to stress hormones: distinguishing beneficial from detrimental stress. Frontiers in. Physiology. 2015;77.
25.
Temple S. The development of neural stem cells. REVIEW ARTICLES. 2001;(6859):112–7.
26.
Tong L, Fong H, Huang Y. Stem cell therapy for Alzheimer’s disease and related disorders: current status and future perspectives. Exp Mol Med. 2015;151.
27.
Adami R, Scesa G, Bottai D. Stem cell transplantation in neurological diseases: improving effectiveness in animal models. Front Cell Dev Biol. 2014;17.
28.
Ortiz-Gonzalez X, Keene C, Verfaillie C, Low W. Neuralinduction of adult bone marrow and umbilical cord stem cells. CurrNeurovasc Res. 2004;(3):207–13.
29.
La Tassa MD, Arias-Rodríguez G, M. Treatment of motor symptoms in Parkinson’s disease. Rev Neurol. 2009;(Suppl 1):27–31.
30.
Hauser R. Early pharmacologic treatment in Parkinson’s disease. Am J Manag Care. 2010;100–7.
31.
Olanow C, Rascol O, Hauser R, Feigin P, Jankovic J, Lang A, et al. A double-blind, delayed-start trial of rasagiline in Parkinson’s disease. N Engl J Med. 2009;1268–78.
32.
Lindvall O, Kokaia Z. Stem cells for the treatment of neurologicaldisorders. Nature. 2006;(7097):1094–6.
33.
Lindvall O, Rehncrona S, Brundin P, Gustavii B, Astedt B, Widnerh, et al. Human fetal dopamine neurons grafted into thestriatum in two patients with severe Parkinson’s disease. Adetailed account of methodology and a 6-month follow-up. Arch Neurol. 1989;(6):615–31.
34.
Kordower J, Freeman T, Snow B, Vingerhoets F, Mufson E, Sanberg P, et al. Neuropathological evidence of graft survivaland striatal reinnervation after the transplantation of fetal mesencephalictissue in a patient with Parkinson’s disease. N EnglJ Med. 1995;(17):1118–24.
35.
Piccini P, Brooks D, Björklund A, Gunn R, Grasby P, Rimoldio, et al. Dopamine release from nigral transplants visualized invivo in a Parkinson’s patient. Nat Neurosci. 1999;(12):1137–40.
36.
Olanow C, Goetz C, Kordower J, Stoessl A, Sossi V, Brinmf, et al. A double-blind controlled trial of bilateral fetal nigraltransplantation in Parkinson’s disease. Ann Neurol. 2003;(3):403–14.
37.
Piccini P, Pavese N, Hagell P, Reimer J, Björklund A, Oertel W, et al. Factors affecting the clinical outcome after neural transplantationin Parkinson’s disease. Brain. 2005;2977–86.
38.
Gill S, Patel N, Hotton G, ’sullivan O, Mccarter K, Bunnagem R, et al. Direct brain infusion of glial cell line-derived neurotrophicfactor in Parkinson disease. Nat Med. 2003;(5):589–95.
39.
Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012;1204–22.
40.
Yu D, Marchetto M, Gage F. Therapeutic translation of iPSCs for treating neurological disease. Cell Stem Cell. 2013;678–88.
41.
Tong L, Fong H, Huang Y. Stem cell therapy for Alzheimer’s disease and related disorders: current status and future perspectives. Experimental & Molecular Medicine. 2015;(3):151.
42.
Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello N, Müller F, Loring J, et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl AcadSci USA. 2009;13594–9.
43.
Park D, Joo S, Kim T, Lee S, Kang H, Lee H, et al. Human neural stem cells overexpressing choline acetyltransferase restore cognitive function of kainic acid-induced learning and memory deficit animals. Cell Transplant. 2012;365–71.
44.
Yamasaki T, Blurton-Jones M, Morrissette D, Kitazawa M, Oddo S, Laferla F. Neural stem cells improve memory in an inducible mouse model of neuronal loss. J Neurosci. 2007;11925–33.
45.
Suksuphew S, Noisa P. Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases. World J Stem Cells. 2015;(2):502–11.
46.
Elder G, Gasperi D, R, Sosa G, M. Research update: neurogenesis in adult brain and neuropsychiatric disorders. Mt Sinai J Med. 2006;(7):931–40.
47.
Hodges H, Veizovic T, Bray N, French S, Rashid T, Chadwick A, et al. Conditionally immortal neuroepithelial stem cell grafts reverse age-associated memory impairments in rats. Neuroscience. 2000;(4):945–55.
48.
Malberg J. Implications of adult hippocampal neurogenesis in antidepressant action. J Psychiatry Neurosci. 2004;(3):196–205.
49.
Vučelj S, Zećović E, Nurković J. Mogućnostimagnetnerezonance u procenivolumenahipokampalneformacije. IX/XV kongresneu-rologaSrbijesameđunarodnimučešćem. 2013;144.
50.
Shin J, Park H, Kim H, Oh S, Bae J, Ha H, et al. Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models. Autophagy. 2014;32–44.
51.
Park D, Yang G, Bae D, Lee S, Yang Y, Kim K, et al. Human adipose tissue-derived mesenchymal stem cells improve cognitive function and physical activity in ageing mice. J Neurosci Res. 2013;660–70.
52.
Maler J, Spitzer P, Lewczuk P, Kornhuber J, Herrmann M, Wiltfang J. Decreased circulating CD34+ stem cells in early Alzheimer’s disease: Evidence for a deficient hematopoietic brain support? Mol Psychiatry. 2006;(12):1113–5.
53.
Cogle C, Yachnis A, Laywell E, Zander D, Wingard J, Steindler D, et al. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet. 2004;(9419):1432–7.
54.
Fischer W, Wictorin K, Björklund A, Williams L, Varon S, Gage F. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 1987;(6134):65–8.
55.
Tuszynski M, Thal L, Pay M, Salmon D, Hs U, Bakay R, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005;(5):551–5.
56.
Aleynik A, Gernavage K, Mourad Y, Sherman L, Liu K, Gubenko Y, et al. Stem cell delivery of therapies for brain disorders. Clinical and Translational Medicine. 2014;24.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
